These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21258088)

  • 1. Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor.
    Guha M; Heier A; Price S; Bielenstein M; Caccese RG; Heathcote DI; Simpson TR; Stong DB; Bodes E
    Toxicol Sci; 2011 Apr; 120(2):269-83. PubMed ID: 21258088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.
    Betton GR; Ennulat D; Hoffman D; Gautier JC; Harpur E; Pettit S
    Toxicol Pathol; 2012 Jun; 40(4):682-94. PubMed ID: 22301952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys.
    Chen Y; Dale Thurman J; Kinter LB; Bialecki R; Eric McDuffie J
    Toxicol Appl Pharmacol; 2017 Dec; 336():66-74. PubMed ID: 29051111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical identification of kidney nephron segments in the dog, rat, mouse, and cynomolgus monkey.
    Bauchet AL; Masson R; Guffroy M; Slaoui M
    Toxicol Pathol; 2011 Dec; 39(7):1115-28. PubMed ID: 22006284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.
    Gautier JC; Zhou X; Yang Y; Gury T; Qu Z; Palazzi X; Léonard JF; Slaoui M; Veeranagouda Y; Guizon I; Boitier E; Filali-Ansary A; van den Berg BHJ; Poetz O; Joos T; Zhang T; Wang J; Detilleux P; Li B
    Toxicol Appl Pharmacol; 2016 Jul; 303():1-10. PubMed ID: 27105553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunolocalization of novel corticomedullary tubule injury markers in Cynomolgus monkeys treated with amphotericin B.
    McDuffie JE; Ma JY; Zhang Y; Almy FS; Wu X; Li K; Sonee M; Meng R; Rizzolio M; Snook SS
    J Toxicol Sci; 2017; 42(2):167-174. PubMed ID: 28321043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.
    Hoffmann D; Fuchs TC; Henzler T; Matheis KA; Herget T; Dekant W; Hewitt P; Mally A
    Toxicology; 2010 Nov; 277(1-3):49-58. PubMed ID: 20816719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of novel acute urinary rat kidney toxicity biomarker for subacute toxicity studies in preclinical trials.
    Fuchs TC; Frick K; Emde B; Czasch S; von Landenberg F; Hewitt P
    Toxicol Pathol; 2012 Oct; 40(7):1031-48. PubMed ID: 22581810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
    Shao L; Wang F; Malcolm SC; Ma J; Hewitt MC; Campbell UC; Bush LR; Spicer NA; Engel SR; Saraswat LD; Hardy LW; Koch P; Schreiber R; Spear KL; Varney MA
    Bioorg Med Chem; 2011 Jan; 19(1):663-76. PubMed ID: 21093273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
    Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
    Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute biomarker panel changes associated with amphotericin B nephrotoxicity in female Sprague-Dawley rats.
    McDuffie JE; Lee S; Ma JY; Chen Y; Snook S
    J Toxicol Sci; 2016; 41(4):459-68. PubMed ID: 27432232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antidepressant activity, and toxicity of the erythro/threo racemates and optical isomers of 2-(4-benzylpiperazin-1-yl)-1-(5-chloro-6-methoxynaphthalen-2-yl)hexan-1-ol.
    Weng Z; Zheng Y; Li J
    Chem Biol Drug Des; 2015 Apr; 85(4):454-60. PubMed ID: 25243904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers.
    Keirstead ND; Wagoner MP; Bentley P; Blais M; Brown C; Cheatham L; Ciaccio P; Dragan Y; Ferguson D; Fikes J; Galvin M; Gupta A; Hale M; Johnson N; Luo W; McGrath F; Pietras M; Price S; Sathe AG; Sasaki JC; Snow D; Walsky RL; Kern G
    Toxicol Sci; 2014 Feb; 137(2):278-91. PubMed ID: 24189134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin a in vivo and in vitro.
    Rached E; Hoffmann D; Blumbach K; Weber K; Dekant W; Mally A
    Toxicol Sci; 2008 Jun; 103(2):371-81. PubMed ID: 18308701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug safety evaluation through biomarker analysis--a toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer.
    Hsieh FY; Tengstrand E; Lee JW; Li LY; Silverman L; Riordan B; Miwa G; Milton M; Alden C; Lee F
    Toxicol Appl Pharmacol; 2007 Oct; 224(1):12-8. PubMed ID: 17681578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.